As of 23 April 2026, the HTA Council has completed the evidence appraisal on the assessment of the following drugs for their respective indications, for possible government financing: The health technologies were reviewed vis-à-vis the Philippine Food and Drug Administration (FDA) marketing authorization status, clinical practice guidelines (CPGs) [local and approved by the Department of continue reading : HTA Council Preliminary Recommendation on Paroxetine, Vortioxetine and Brexpiprazole for treatment of mental health conditions